Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors

15Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

New compounds were tested in vitro on aromatase activity in human placental and equine testicular microsomes. Equine aromatase, very well characterized biochemically, is used as a comparative model to understand the mechanism of aromatase inhibition. Among 15 molecules screened, 5 of them (11-15) strongly inhibit human and equine aromatases with IC50 values ranging from 13-85 nM and from 23-103 nM respectively. These results were corroborated by Ki/Km values. Moreover, spectral studies showed a type II spectrum with both enzymes, which is characteristic of an interaction between the nitrogen atom of the molecule and the heme of the cytochrome P450. Compound 12, which has the lowest IC50 and Ki/Km ratio, inactivates aromatase in a dose and time-dependent manner. This might be very important for the treatment of estrogen-dependent diseases such as breast cancer. Finally, MTT assays on E293 cells revealed that the molecules were not cytotoxic. © 2004 Taylor & Francis Ltd.

Cite

CITATION STYLE

APA

Nativelle-Serpentini, C., Moslemi, S., Yous, S., Park, C. H., Lesieur, D., Sourdaine, P., & Séralini, G. E. (2004). Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 19(2), 119–127. https://doi.org/10.1080/14756360410001667319

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free